Optimizing Therapy in RA:Update on Long-Term Strategies
HIGHLIGHTS OF CLINICAL STUDIES
This CME supplement to Rheumatology News is supported by an educational grant from UCB Pharma. Full TextPDF
Biologic Agents:Practice Implications and Improved Patient Outcomes
This CME supplement to Rheumatology News is supported by Roche. Full TextPDF
Unmet Needs in RA: The Role of Anti-TNF Therapy
This CME supplement to Rheumatology News is supported by educational grants from Centocor and UCB. Full TextPDF
Capitalizing on Advances in Rheumatoid Arthritis: Optimizing Patient Assessment
Highlights of Recently Presented Studies
A supplement to Rheumatology News and supported by an independent educational grant from Roche. This supplement was jointly sponsored by the American Academy of CME, Inc. and Alliance Medical Communications.
This activity is developed from scientific information presented at the 2009 European League Against Rheumatism (EULAR) annual congress convened in Copenhagen, Denmark, June 10-13, 2009. Full TextPDF
Recent Developments in Anti-TNF Therapy for Rheumatoid Arthritis
Highlights of Selected Clinical Presentation and Studies
A supplement to Rheumatology News and supported by an educational grant from UCB. This activity is co-provided by Creative Educational Concepts, Inc. (CEC), and Rheumatology News.
This supplement is based on selected abstracts and clinical posters presented at the American College of Rheumatology Annual Meeting (ACR) held October 24-29, 2008, in San Francisco, California. Full TextPDF
Novel Biologic Agents in the Treatment of Rheumatoid Arthritis: Which Target Pathway Next?
A supplement to Rheumatology News and supported by an independent educational grant from Roche. This supplement was jointly sponsored by the American Academy of CME and Alliance Medical Communications.
This activity is based upon a live CME symposium that took place on Tuesday, October 28, 2008, in San Francisco, CA. Full TextPDF
The Evolving Role of TNF Inhibition in the Treatment of Rheumatoid Arthritis
A supplement to Rheumatology News and supported by an educational grant from UCB, Inc. This supplement was jointly sponsored by the Elsevier Office of Continuing Medical Education and Rheumatology News
This supplement is based on selected abstracts and clinical posters presented at the European Congress of Rheumatology (EULAR) held June 11-14, 2008, in Paris, France. Commentary sections are based on interviews with the faculty. Full TextPDF
Biologics in Rheumatoid Arthritis: Latest Developments and Practical Aspects
Highlights of a Roundtable
A supplement to Rheumatology News and funded through an educational grant from Genentech/Biogen Idec. This supplement was sponsored by DIME.This supplement is based on presentations at the Rheumatoid Arthritis Roundtable Meeting "Biologics in Rheumatoid Arthritis: Latest Developments and Practical Aspects," held on April 18, 2008, at the Westin O'Hare in Rosemont, Illinois. Full TextPDF
Rheumatoid Arthritis: Meeting the Patient-Care Challenge
A supplement to Rheumatology News Nurse Practitioner and supported by an educational grant from UCB, Inc. This supplement was jointly sponsored by the Elsevier/ Mosby Office of Continuing Nurse Education and Rheumatology News.
This supplement is based on faculty interviews.
Full TextPDF
Reducing Fracture Risk: Strategies for the Prevention and Treatment of Osteoporosis
A supplement to Rheumatology News supported by an educational grant from Lilly. This supplement is based on a symposium that was held on April 19, 2007, in Washington, DC, and is jointly sponsored by Cedars-Sinai Medical Center and The Partnership for Medical Education. Full TextPDF
Assessing Cardiovascular Risk in the Patient With Lupus
A supplement to Rheumatology News supported by an unrestricted educational grant from Aspreva Pharmaceuticals. This supplement is based on faculty interviews and is jointly sponsored by The Elsevier Office of Continuing Medical Education (EOCME), an ACCME accredited provider, and Rheumatology News. Full TextPDF
Renal and Nonrenal Flares in Systemic Lupus Erythematosus: Meeting the Clinical Challenge
A supplement to Rheumatology News supported by an unrestricted educational grant from Aspreva Pharmaceuticals. This supplement was jointly sponsored by Elsevier/International Medical News Group and Boston University School of Medicine, an ACCME accredited provider.
The articles in this supplement are based on a continuing medical education symposium held November 15, 2006, in Washington, DC. Full TextPDF
The Expanding Role of TNF Inhibitors: Therapeutic Advances in Psoriasis and Psoriatic Arthritis
A supplement to Rheumatology News supported by an unrestricted educational grant from Abbott Immunology. This supplement was jointly sponsored by The Elsevier Office of Continuing Medical Education (EOCME), an ACCME accredited provider, and Rheumatology News.
The articles in this supplement are based on a continuing medical education symposium held on July 20, 2005, in Chicago. Full TextPDF
The Emerging Role of TNF Blockade in the Treatment of Psoriatic Arthritis and Psoriasis
A supplement to Rheumatology News.
Sponsored by Medical Education Resources (MER) Inc.
Supported by an unrestricted educational grant from Wyeth and Amgen.
Highlights of presentations based on a satellite symposium program held June 30, 2002, in Paris, France. Full TextPDF
Controversies in the Treatment of Rheumatoid Arthritis
A supplement to Rheumatology News.
Sponsored by Medical Education Resources (MER) Inc.
Supported by an unrestricted educational grant from Wyeth and Amgen.
Highlights of presentations based on a satellite symposium program held June 12, 2002, in Stockholm, Sweden. Full TextPDF
Biologic Therapies for Rheumatoid Arthritis: Navigating the Changing Treatment Paradigm
A supplement to Rheumatology News.
Sponsored by Medical Education Resources (MER) Inc.
Supported by an unrestricted educational grant from Wyeth and Amgen. Full TextPDF
